Jeiven Pharmaceutical Consulting
Private Company
Funding information not available
Overview
Jeiven Pharmaceutical Consulting, founded in 2010, is a private, revenue-generating services firm focused exclusively on the niche of drug delivery and formulation science. The company acts as an external expert partner for pharmaceutical and biotech companies, offering strategic consulting and hands-on development support to enhance drug solubility, stability, bioavailability, and manufacturability. Its business model is built on providing specialized technical and regulatory guidance, with no proprietary therapeutic pipeline of its own. Jeiven's value proposition lies in its ability to de-risk and accelerate client programs through applied expertise in advanced drug delivery systems.
Technology Platform
Integrated knowledge and methodological expertise in drug delivery systems and formulation science, including amorphous solid dispersions, lipid-based systems, controlled release, and patient-centric dosage forms.
Opportunities
Risk Factors
Competitive Landscape
Jeiven competes in a specialized segment against the formulation consulting arms of large CROs (e.g., Lonza, Catalent, Labcorp) and other boutique consulting firms. Its differentiation is its pure-play focus, deep expertise, and likely more personalized service compared to larger players. Competition is based on scientific reputation, track record, and the ability to solve uniquely difficult problems.